Optiver Holding
NPCE icon

Optiver Holding’s Neuropace NPCE Stock Holding History

Optiver Holding’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$985 Sell
62
-192
-76% -$3.09K ﹤0.01% 2492
2026
Q1 		$3.34K Sell
254
-16
-6% -$240 ﹤0.01% 1607
2025
Q4 		$4.17K Sell
270
-162
-38% -$2.17K ﹤0.01% 1502
2025
Q3 		$4.45K Buy
+432
New +$4.07K ﹤0.01% 1842

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Optiver Holding's NPCE Position: Q2 2026 in Review

Optiver Holding reduced its Neuropace (NPCE) stake by 76% in Q2 2026, selling an estimated $3.09K and leaving 62 shares worth $985. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

Optiver Holding first reported a position in NPCE in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.45K in Q3 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Optiver Holding held 62 shares of Neuropace worth $985 as of Q2 2026.
  • Optiver Holding sold 192 Neuropace shares in Q2 2026, an estimated $3.09K.
  • Neuropace made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2492 holding.
  • Optiver Holding first reported a position in Neuropace in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Neuropace position peaked at $4.45K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.